Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-1-23
pubmed:abstractText
We classified CD56+ CD3- natural killer (NK) cells into CD2- CD56dim (CD2- NK), CD2+ CD56dim (CD2+ NK) and CD2+ CD56bright populations, and investigated mainly functional differences between the former two populations. CD2- and CD2+ NK cells were the same in their morphology and several surface molecules except for CD2. The percentages of CD2- NK cells in total NK cells were higher in the cord blood and marrow than in the peripheral blood of adults or children. Freshly isolated CD2- NK cells had CD2 in the cytoplasm, and gradually expressed it on the surface upon incubation with interleukin-2 (IL-2). These results demonstrated that CD2 is an antigen which appears on the surface during the maturation of NK cells. The granule-mediated cytotoxicities, which are mainly performed by the perforin molecule, of CD2+ NK cells against K562 and Daudi cells were higher than those of CD2- NK cells, and they were inhibited to the levels of CD2- NK cells by the addition of a blocking anti-CD2 monoclonal antibody (mAb). Fas ligand (FasL) mRNA was expressed in freshly isolated CD2+ NK cells but not in the CD2- NK cells. Neither freshly isolated NK populations showed FasL-mediated cytotoxicity, and only CD2+ NK cells lysed Fas-transfected targets after the 24-hr incubation with IL-2. Based on these results, CD2- NK cells have already developed granule-mediated cytotoxicity equal to that of CD2+ NK cells except for the CD2-associated activity, but they, unlike CD2+ NK cells, totally lack FasL-mediated cytotoxicity. These findings suggest that FasL-mediated cytotoxicity may be acquired at more mature stages of NK-cell maturation than granule-mediated cytotoxicity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-1384796, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-1692080, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-1700001, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-1700360, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-2265240, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-2420467, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-2530273, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-2864636, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-2951597, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-3086432, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-3098784, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-3312414, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-6231105, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-6332169, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7252409, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7497525, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7513206, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7532682, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7679691, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7683037, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7742523, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7826947, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-7878463, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-8164737, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-8621902, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-8690463, http://linkedlifedata.com/resource/pubmed/commentcorrection/9415024-8816396
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
180-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells.
pubmed:affiliation
Department of Paediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
pubmed:publicationType
Journal Article